Key result
Echo detects rare fatal haemorrhagic myocarditis linked to cyclophosphamide therapy.
Echocardiography can be used to identify the ultrasound features of fatal haemorrhagic myocarditis, a rare complication of cyclophosphamide therapy.
May signal rare fatal myocarditis risk with cyclophosphamide; single case leaves echocardiographic screening utility open.
Haemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported.
No takes yet. Share an insight, caveat, or question.
Birchall et al. (2000) studied this question. Cyclophosphamide therapy can lead to fatal haemorrhagic myocarditis, a rare complication that can be identified using echocardiography.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: